A brand new biotech – Neurosterix – has been formed to take forward neuroscience programmes that originated at Switzerland’s Addex Therapeutics, including a drug for schizophrenia. Neurosterix has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results